{"name":"TesoRx Pharma, LLC","slug":"tesorx-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TSX-002","genericName":"TSX-002","slug":"tsx-002","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"TSX-002","genericName":"TSX-002","slug":"tsx-002","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOUlZoOWpUS0ppdmNzOHJuaG5JRTVRS3EwVk1zQ2FMQUNKSXY1bEVDLWFtUFM5NFlRUzB6MXhuczJVbWc1SVBMQ1hHOEJPUWRmSW41WVh3dXFROUdsTUJfY0E4OEo5cU14QXZCT0pQYVpCMnl6Mjh0enBFdm50Nnh1cXpPdmtJTjNYOXRhUkRWM1BwU29URTc0SmowM0VCVmNnWmpCcWY1UTZYNVVSeS0xamYzTldYU29HY3hvdWlYcHN1SGVOMURvb0I1WUFRM29DbTJiTFNkd0JTQ1hya0s4LWFoOTVidF9zMmdhbg?oc=5","date":"2017-04-27","type":"trial","source":"BioSpace","summary":"ASKA Pharmaceutical And TesoRx Announce TSX-011 (Oral Testosterone) Proceeding To Human Studies Following Successful PK Study Results - BioSpace","headline":"ASKA Pharmaceutical And TesoRx Announce TSX-011 (Oral Testosterone) Proceeding To Human Studies Following Successful PK ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQSG5JM2thdS1VeFlDWEYwRWc2S25mWFBMT2JXc0tSbVhqQ2VwT2Y5aExwTU9aTkxWMVl4WHhFTXZFbmNSYWh3ckpWQWh0U1RTMFphOXJ4N2pmN1QwWHBPTHgtQjk2amxwVXVSWUZLR1NReWlGNWw2YXY4QW1ITktmR01rT3puLTRoS1llRFlCMWVVR0xxazFYMXNhcUdIYnpmd2NCQjBiLWRIbkc4N2xzUU5KZGpLdzRQMl9oQXJBQXozX3ZTWVhaYW5FT09Ed1B6QlEtTGQ4Rk5pREhvN0VjSHZjamxEYjlYeTZyMzNn?oc=5","date":"2014-08-05","type":"patent","source":"PR Newswire","summary":"TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer - PR Newswire","headline":"TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}